Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Furnari

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaFernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.
Cancer Research|August 20, 2009
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patientsKan V Lu, Shaojun Zhu, Anna Cvrljevic, et al.
Cancer Cell|October 18, 2016
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain CancersGenaro R Villa, Jonathan J Hulce, Ciro Zanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.
Cancer Cell|July 11, 2018
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic DevelopmentZev A Binder, Amy Haseley Thorne, Spyridon Bakas, et al.
Acta Neuropathologica Communications|June 28, 2025
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastomaBenjamin Lin, Abigail K Shelton, Erin Smithberger, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature|November 22, 2019
Circular ecDNA promotes accessible chromatin and high oncogene expressionSihan Wu, Kristen M Turner, Nam Nguyen, et al.
The Journal of Clinical Investigation|July 26, 2014
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesisHaizhong Feng, Giselle Y Lopez, Chung Kwon Kim, et al.
Genes & Development|July 21, 2017
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivityCiro Zanca, Genaro R Villa, Jorge A Benitez, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaFernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.
Cancer Research|August 20, 2009
Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patientsKan V Lu, Shaojun Zhu, Anna Cvrljevic, et al.
Cancer Cell|October 18, 2016
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain CancersGenaro R Villa, Jonathan J Hulce, Ciro Zanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.
Cancer Cell|July 11, 2018
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic DevelopmentZev A Binder, Amy Haseley Thorne, Spyridon Bakas, et al.
Acta Neuropathologica Communications|June 28, 2025
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastomaBenjamin Lin, Abigail K Shelton, Erin Smithberger, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Breakage fusion bridge cycles drive high oncogene copy number, but not intratumoral genetic heterogeneity or rapid cancer genome changeSiavash Raeisi Dehkordi, Ivy Tsz-Lo Wong, Jing Ni, et al.
Nature|November 22, 2019
Circular ecDNA promotes accessible chromatin and high oncogene expressionSihan Wu, Kristen M Turner, Nam Nguyen, et al.
The Journal of Clinical Investigation|July 26, 2014
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesisHaizhong Feng, Giselle Y Lopez, Chung Kwon Kim, et al.
Genes & Development|July 21, 2017
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivityCiro Zanca, Genaro R Villa, Jorge A Benitez, et al.
Pageof 12